Leana Wen, M.D., MSc
Board Member
UroGen Pharma Ltd. (URGN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Leana Wen, M.D., MSc
Leana Wen, M.D., MSc is recorded as Board Member at UroGen Pharma Ltd. (URGN). UroGen Pharma Ltd. reported in an 8-K filed September 12, 2022 that Leana Wen, M.D., MSc was appointed board of directors, effective September 8, 2022.
“On September 8, 2022, Leana Wen, M.D., MSc was appointed to the board of directors (the "Board") of UroGen Pharma Ltd., an Israeli company (the "Company"), to fill a vacancy on the Board and to hold office until the Company's 2023 Annual Meeting of Shareholders and was also appointed to the Audit Committee of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-09-08–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at UroGen Pharma Ltd.
Other people whose current roles at this company are on record from its filings.
- Elizabeth Barrett CEO, Board Member
- Arie Belldegrun Chairman, Board Member
- Chris Degnan CFO
- Dong (Don) Kim CFO
- Stephen L. Mullennix COO
- Jason Smith General Counsel
- Christopher Degnan Chief Accounting Officer
- Arie Belldegrun, M.D. Board Member
- Arie Belldegrun, M.D., FACS Board Member
- Cynthia M. Butitta Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.